Table 1.
Epidemiological characteristics and seizure frequency in our sample before and during COVID-19 confinement.
| Worsening | No change | Improvement | ||
|---|---|---|---|---|
| n | 3 | 28 | 18 | |
| Age (years), mean (SD) | 51.7 (24.6) | 56.2 (22.8) | 3.6 (19.8) | |
| Sex, n (%) | Men | 2 (66.7%) | 12 (42.9%) | 12 (66.7%) |
| Women | 1 (33.3%) | 16 (57.1%) | 6 (33.3%) | |
| Seizure type, n (%) | Focal | 2 (66.7%) | 17 (60.7%) | 11 (61.1%) |
| Generalised | 1 (33.3%) | 11 (39.3%) | 7 (38.9%) | |
| Epilepsy aetiology, n (%) | Structural | 1 (33.3%) | 16 (57.1%) | 10 (55.6%) |
| Genetic | 2 (66.7%) | 12 (42.9%) | 8 (44.4%) | |
| No. monthly seizures before confinement, mean (SD) | 13.4 (19.1) | 1.1 (5.7) | 4.3 (11.7) | |
| No. monthly seizures during confinement, mean (SD) | 20.3 (22.5) | 1.1 (5.7) | 2.3 (7.1) | |
| No. AEDs, mean (SD) | 3.3 (1.5) | 1.2 (0.4) | 2.1 (1.1) | |
AED: antiepileptic drug; SD: standard deviation.